None

Horizon Discovery Announces Oncology Drug Discovery Collaboration with AstraZeneca (News)

22 April 2013: Cambridge, UK - Horizon Discovery (Horizon) and AstraZeneca have entered into an exclusive collaboration and license agreement to explore Horizon's first-in-class kinase ...

Horizon Pharma to Present at the Stifel Nicolaus Healthcare Conference

DEERFIELD, IL -- (Marketwire) -- 08/22/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Stifel...

Horizon Pharma to Present at the BioCentury NewsMakers in the Biotech Industry Conference

DEERFIELD, IL -- (Marketwire) -- 08/24/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the BioCentu...

Horizon Pharma to Present at the 7th Annual JMP Securities Healthcare Conference

DEERFIELD, IL -- (Marketwire) -- 06/29/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd N. Smith, Executive Vice President and Chief Commercial Officer, will present at the JMP Se...

Horizon Pharma to Present at the 11th Annual BIO Investor Forum

DEERFIELD, IL -- (Marketwire) -- 09/27/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 11th Annua...

Horizon Pharma to Host an Investment Community Briefing on RAYOS(R) on Monday, November 12, 2012

DEERFIELD, IL -- (Marketwire) -- 10/29/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that it will host a live webcast to discuss the approval and initial launch of RAYOS® on Monday, Nove...

Horizon Pharma to Present at the 15th Annual BIO CEO and Investor Conference

DEERFIELD, IL -- (Marketwire) -- 02/04/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, is scheduled to present at t...

FDA approves Horizon's Rayos

FDA approved an NDA from Horizon Pharma Inc. (NASDAQ:HZNP) for Rayos prednisone delayed-release tablets to treat a broad range of diseases, including rheumatoid arthritis (RA), polymyalgia rheumatica,...

Spectral UV radiance measured at a coastal site: a case study.

We have sampled the spatial distribution of the UV radiation (i.e. the UV radiance) at a station located on the southern pacific coastline (Valparaiso, Chile, 33.03°S-71.58°W). The site is character...

Deepwater Horizon: After the oil.

Incubation of air-pollution-control residues from secondary Pb smelter in deciduous and coniferous organic soil horizons: Leachability of lead, cadmium and zinc.

The leachability of air-pollution-control (APC) residues from a secondary lead smelter in organic soil horizons (F and H) from a deciduous and a coniferous forest during incubation periods of 0, 3 and...

Horizon 2020.

Deepwater Horizon: A scientist at the centre of the spill.